Baseline (BL) features and metastasis-free survival (MFS) by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR): EMBARK post hoc analysis
Publication
, Conference
Shore, ND; Sridharan, S; Venugopal, B; Rannikko, A; Sieber, P; De Giorgi, U; Moul, JW; Woo, HH; Tang, Y; Croitoru, R; Rosales, M; Peraud, O ...
Published in: ANNALS OF ONCOLOGY
2025
Duke Scholars
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
2025
Volume
36
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Shore, N. D., Sridharan, S., Venugopal, B., Rannikko, A., Sieber, P., De Giorgi, U., … Freedland, S. (2025). Baseline (BL) features and metastasis-free survival (MFS) by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR): EMBARK post hoc analysis. In ANNALS OF ONCOLOGY (Vol. 36).
Shore, N. D., S. Sridharan, B. Venugopal, A. Rannikko, P. Sieber, U. De Giorgi, J. W. Moul, et al. “Baseline (BL) features and metastasis-free survival (MFS) by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR): EMBARK post hoc analysis.” In ANNALS OF ONCOLOGY, Vol. 36, 2025.
Shore ND, Sridharan S, Venugopal B, Rannikko A, Sieber P, De Giorgi U, et al. Baseline (BL) features and metastasis-free survival (MFS) by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR): EMBARK post hoc analysis. In: ANNALS OF ONCOLOGY. 2025.
Shore, N. D., et al. “Baseline (BL) features and metastasis-free survival (MFS) by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR): EMBARK post hoc analysis.” ANNALS OF ONCOLOGY, vol. 36, 2025.
Shore ND, Sridharan S, Venugopal B, Rannikko A, Sieber P, De Giorgi U, Moul JW, Woo HH, Tang Y, Croitoru R, Rosales M, Peraud O, Wang F, Freedland S. Baseline (BL) features and metastasis-free survival (MFS) by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR): EMBARK post hoc analysis. ANNALS OF ONCOLOGY. 2025.
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
2025
Volume
36
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis